Clinical Trial Update: Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dose-dense biweekly carboplatin plus paclitaxel with or without trastuzumab as neoadjuvant therapy for breast cancer; current status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN